Submucosal steroid pre-injection strategy to prevent oesophageal stricture after circumferential endoscopic submucosal dissection

Ke Zhan,Pengfei Wang,Wei-hui Liu,Yang Bai,Daorong Chen,Ling Sun,Min Qiao,Jianhua Dai,Xusheng Nie,Xin Yang
DOI: https://doi.org/10.1136/gutjnl-2024-333098
IF: 24.5
2024-10-08
Gut
Abstract:Message Oesophageal strictures following circumferential endoscopic submucosal dissection (cESD) for extended early oesophageal cancer remain an unresolved issue since they are often treatment-refractory. We present a strategy to use topical steroids for submucosal injection during ESD followed by two postprocedural injection sessions. Doses between 70 and 120 mg of triamcinolone (2 mg/mL) were used. During a follow-up of a mean of 6 months (range: 3–12 months), only 1/9 of patients developed a stricture which resolved after one dilatation session. No adverse events were noted. This concept should be tested further in larger prospective trials. In more detail Oesophageal stricture after cESD is emerging as a major concern given that it occurs at a high rate of 100% and leads to poor quality of life.1–5 Despite the proposal of several approaches to prevent post-cESD stricture, these strategies...
gastroenterology & hepatology
What problem does this paper attempt to address?